Observational studyBMC cancer2022

A real-world retrospective study of the use of Ki-67 testing and treatment patterns in patients with HR+, HER2- early breast cancer in the United States.

Jacqueline Brown et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.